Ankara Bilkent City Hospital
Ankara, None Selected, 06800, Turkey (Türkiye)
NCT Number: NCT07114575
Stroke is the second leading cause of death and the third leading cause of death combined with disability worldwide. Despite improved recognition and management of stroke risk factors, the risk of stroke has increased by 50% in the last two decades due to increased life expectancy, currently affecting one in every four individuals. If this trend continues, by 2030, it is estimated that 12 million people will die from stroke, and 70 million will live with its consequences.
Stroke leads to significant changes in the spatiotemporal parameters of gait. Spatial parameters include step length, stride length, and step width, while temporal parameters comprise cadence, stance phase, double support phase (DSP), and swing phase. Gait speed, incorporating both spatial and temporal elements, is classified as a spatiotemporal parameter. Compared to healthy individuals, people post-stroke tend to have increased DSP and stance phases, shortened step lengths, and widened step widths. Asymmetries between the paretic and non-paretic limbs further disrupt gait symmetry.
Previous studies have shown that during prolonged walking tasks such as the 6-minute walk test, both gait speed and symmetry deteriorate in the later stages, potentially due to fatigue. However, changes in walking speed itself may also influence gait symmetry. From this perspective, the aim of this study is to investigate how spatiotemporal gait parameters vary across different walking speeds in individuals with stroke.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Ankara, None Selected, 06800, Turkey (Türkiye)
Stroke is one of the leading causes of death and disability worldwide, with increasing prevalence due to longer life expectancy, despite improved recognition and management of risk factors. Stroke-related impairments, particularly in gait, significantly affect individuals' independence and quality of life. Post-stroke gait is commonly characterized by altered spatiotemporal parameters, including reduced step length, increased double support phase, asymmetry between paretic and non-paretic limbs, and reduced walking speed.
This descriptive study aims to investigate how different walking speeds affect the spatiotemporal gait parameters in individuals with stroke. Specifically, the study will examine walking at comfortable, slow (-25%), and fast (+25%) speeds using an instrumented treadmill (C-Mill). The target population includes adult individuals (18+) diagnosed with hemiplegia (ICD-10: G81), who are able to ambulate with or without assistance (Functional Ambulation Classification ≥2).
Spatiotemporal gait parameters, including step length, step width, cadence, stance and swing phases, and double support time, will be collected for both paretic and non-paretic limbs. These parameters will be assessed at three different walking speeds. In addition to gait analysis, functional status will be evaluated using the Functional Ambulation Classification (FAC), Berg Balance Scale (BBS), and the lower extremity section of the Fugl-Meyer Assessment (FMA-LE). Demographic and clinical information will also be recorded.
Participants will first walk at their comfortable speed to familiarize themselves with the treadmill and to determine baseline parameters. After a 2-minute warm-up walk, a 2-minute data collection phase will follow. The same procedure will be repeated at the slow and fast walking speeds. Gait symmetry and changes in temporal-spatial parameters across walking speeds will be analyzed to explore the influence of speed variation, particularly regarding the mechanisms underlying gait asymmetry and fatigue.
This research will provide insight into how walking speed modulates gait parameters in stroke survivors and may contribute to developing more targeted gait training strategies in neurorehabilitation.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
All participants will undergo gait analysis at three different walking speeds.
Time frame: Baseline
Stance phase of hemiplegic side during walking. This outcome will be obtained as a result of the gait analysis
Time frame: Baseline
Step legth of hemiplegic side during walking. This outcome will be obtained as a result of the gait analysis
Time frame: Baseline
Double support phase during walking. This outcome will be obtained as a result of the gait analysis
Time frame: Baseline
Stride length during walking. This outcome will be obtained as a result of the gait analysis.
Time frame: Baseline
This is a widely used, reliable, and valid test to evaluate motor impairments of the paretic upper and lower extremities in stroke patients. Each item on the scale is scored as 0: unable to perform, 1: partially successful performance, and 2: fully successful performance. Higher scores indicate better motor function. In our study, the 34-point lower extremity section will be used.
Time frame: Baseline
The scale consists of 14 items and assesses the patient's ability to maintain balance (during static or various functional movements) over a certain period. Each item is scored from 0 to 4: 0 points indicate inability to complete the task, while 4 points indicate independent completion of the task. The total maximum score is 56. Scores between 0-20 indicate balance impairment, 21-40 indicate acceptable balance, and 41-56 indicate good balance.
Time frame: Baseline
The scale, which is valid and reliable for patients who develop hemiparesis after stroke, classifies walking ability into six levels based on the amount of physical assistance required (8). A score of 0 indicates that the patient needs assistance from two people to walk, while a score of 5 indicates independent walking in all environments, including stairs.
Ankara Yildirim Beyazıt University
Other
Spatiotemporal Characteristics of Gait at Different Walking Speeds in Individuals With Stroke
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02425345
Arterial Occlusive Diseases, Arteriosclerosis
View Trial DetailsNCT05589402
Bone Diseases, Brain Diseases
Harlingen, Texas, United States
View Trial DetailsNCT06750692
Brain Diseases, Cardiovascular Diseases
Afyonkarahisar, Turkey (Türkiye)
View Trial DetailsNCT04992195
Alzheimer Disease, Arterial Thromboembolism
Hong Kong
View Trial Details